XRF — XRF Scientific Income Statement
0.000.00%
Last trade - 00:00- AU$267.48m
- AU$260.36m
- AU$64.40m
Annual income statement for XRF Scientific, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | 2026 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 40 | 55.3 | 60.1 | 59.4 | 64.4 |
| Cost of Revenue | |||||
| Gross Profit | 17.3 | 23 | 26.5 | 28.8 | 31.7 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Operating Interest Expense / Income | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 31.8 | 43.5 | 46.7 | 44.9 | 49 |
| Operating Profit | 8.19 | 11.8 | 13.5 | 14.6 | 15.4 |
| Net Income Before Taxes | 8.19 | 11.8 | 13.5 | 14.6 | 15.4 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 6.09 | 8.18 | 9.5 | 10.3 | 10.5 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | 6.08 | 7.69 | 8.89 | 10.4 | 10.5 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 6.08 | 7.69 | 8.89 | 10.4 | 10.5 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.045 | 0.056 | 0.064 | 0.074 | 0.073 |
| Dividends per Share |